Nafazolina Pensa (Naphazoline Nitrate)

Naphazoline Nitrate is a selective alpha‑adrenergic agonist. When applied intranasally, it binds to alpha‑adrenergic receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces swelling of the nasal mucosa, opens the airway, and eases breathing.

The exact dose is determined by the prescribing healthcare professional. Typically, the product is administered as one to two sprays per nostril, not exceeding the recommended frequency or duration (usually no more than three consecutive days) to avoid rebound congestion.

Safety data for Naphazoline Nitrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their physician before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nafazolina Pensa (Naphazoline) and products containing oxymetazoline share a similar alpha‑adrenergic mechanism, offering rapid relief of congestion. Naphazoline may have a slightly shorter duration of action, requiring more frequent dosing, while oxymetazoline often provides a longer effect. Both carry comparable risks of rebound congestion if used beyond three days.

Store the nasal spray at room temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the cap tightly closed when not in use and keep out of reach of children.

Nafazolina Pensa is applied intranasally. The user tilts the head slightly forward, inserts the spray tip into a nostril, and delivers the prescribed number of sprays. The same procedure is repeated for the other nostril if required.

Serious adverse events include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant elevation of blood pressure, tachycardia, severe allergic reactions such as anaphylaxis, and rare ocular complications like ischemic optic neuropathy. Prompt medical attention is needed if any of these occur.

Individuals with uncontrolled hypertension, severe coronary artery disease, narrow‑angle glaucoma, recent eye surgery, or known hypersensitivity to Naphazoline Nitrate should avoid using the product. Children under 12 years should not use it unless specifically directed by a healthcare professional.